These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 161335)

  • 1. Role of brain amines in the fetal hyperpyrexia caused by tranylcypromine in LiCl-pretreated rats.
    Shimomura K; Hashimoto M; Mori J; Honda F
    Jpn J Pharmacol; 1979 Apr; 29(2):161-70. PubMed ID: 161335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of brain monoamines in the fatal hyperthermia induced by pethidine or imipramine in rabbits pretreated with a monoamine oxidase inhibitor.
    Gong SN; Rogers KJ
    Br J Pharmacol; 1973 May; 48(1):12-8. PubMed ID: 4269286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of brain 5-hydroxytryptamine in the hyperactivity produced in rats by lithium and monoamine oxidase inhibition.
    Grahame-Smith DG; Green AR
    Br J Pharmacol; 1974 Sep; 52(1):19-26. PubMed ID: 4281339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of caudate nucleus dopamine and cyclic AMP in the hyperpyrexia induced by LiCl plus tranylcypromine in rats.
    Shimomura K; Tomoi M; Mori J
    Jpn J Pharmacol; 1979 Jun; 29(3):447-56. PubMed ID: 43914
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of noradrenaline, dopamine and 5-hydroxytryptamine in the hyperactivity response resulting from the administration of tranylcypramine to rats pretreated with lithium or rubidium.
    Judd A; Parker J; Jenner FA
    Psychopharmacologia; 1975 Apr; 42(1):73-7. PubMed ID: 1153625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of non-selective monoamine oxidase inhibitors, tranylcypromine and nialamide, with inhibitors of 5-hydroxytryptamine, dopamine or noradrenaline re-uptake.
    Marley E; Wozniak KM
    J Psychiatr Res; 1984; 18(2):191-203. PubMed ID: 6235366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible mechanisms involved in the hyperthermic effect caused by reserpine after pretreatment with amphetamine or tranylcypromine in conscious rat.
    Cremades A; Jané F; Serrano JS; Milanés MV
    Methods Find Exp Clin Pharmacol; 1982; 4(8):569-73. PubMed ID: 7169844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Furazolidone-pethidine interaction in rabbits.
    Eltayeb IB; Osman OH
    Br J Pharmacol; 1975 Dec; 55(4):497-501. PubMed ID: 129182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoamines and the mechanisms of action of antitussive drugs in rats.
    Kamei J; Ogawa M; Kasuya Y
    Arch Int Pharmacodyn Ther; 1987 Nov; 290(1):117-27. PubMed ID: 2965557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoaminergic control of episodic growth hormone secretion in the rat: effects of reserpine, alpha-methyl-p-tyrosine, p-chlorophenylalanine, and haloperidol.
    Edén S; Bolle P; Modigh K
    Endocrinology; 1979 Aug; 105(2):523-9. PubMed ID: 156637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of central monoamine compounds on tranylcypromine-induced barbital-withdrawal convulsions.
    Tagashira E; Hiramori T; Nakao K; Urano T; Yanaura S
    Life Sci; 1983 Apr; 32(14):1599-606. PubMed ID: 6682167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of alpha methyltyrosine and parachlorophenylalanine on open field behavior in rats given tranylcypromine stereoisomers and lithium carbonate.
    Smith DF; Shimizu M
    Pharmacol Biochem Behav; 1976 Nov; 5(5):515-8. PubMed ID: 138857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan.
    Grahame-Smith DG
    J Neurochem; 1971 Jun; 18(6):1053-66. PubMed ID: 4254940
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of tranylcypromine on 5-HT uptake and its interaction with PCPA on rat brain 5-HT.
    Friedman E; Shopsin B; Gershon S
    Res Commun Chem Pathol Pharmacol; 1976 Sep; 15(1):191-4. PubMed ID: 135325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of serotonergic agents on the body temperature.
    Pawlowski L
    Pol J Pharmacol Pharm; 1976; 28(6):615-23. PubMed ID: 138132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of brain amines in learning associated with "amphetamine-state".
    Roffman M; Lal H
    Psychopharmacologia; 1972; 25(3):195-204. PubMed ID: 4402958
    [No Abstract]   [Full Text] [Related]  

  • 17. Characteristic hyperpyrexia induced by LiCl and tranylcypromine in rats.
    Shimomura K; Satoh Y; Mori J
    Jpn J Pharmacol; 1980 Apr; 30(2):268-71. PubMed ID: 7452979
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibitory effect of chlorpromazine on the syndrome of hyperactivity produced by L-tryptophan or 5-methoxy-N,N-dimethyltryptamine in rats treated with a monoamine oxidase inhibitor.
    Grahame-Smith DG
    Br J Pharmacol; 1971 Dec; 43(4):856-64. PubMed ID: 4261561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the role of central nervous system catecholamines and 5-hydroxytryptamine in the nialamide-induced behavioural syndrome.
    Modigh K; Svensson TH
    Br J Pharmacol; 1972 Sep; 46(1):32-45. PubMed ID: 4263796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists.
    Green AR; Hall JE; Rees AR
    Br J Pharmacol; 1981 Jul; 73(3):703-19. PubMed ID: 6166345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.